URS
NKTR icon

Utah Retirement Systems’s Nektar Therapeutics NKTR Stock Holding History

Utah Retirement Systems’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,311
Closed -$589K – 960
2020
Q4 		$589K Buy
2,311
+94
+4% +$24.3K 0.01% 813
2020
Q3 		$551K Buy
2,217
+20
+0.9% +$6.29K 0.01% 806
2020
Q2 		$764K Buy
2,197
+66
+3% +$20.6K 0.01% 732
2020
Q1 		$571K Hold
2,131
– – 0.01% 744
2019
Q4 		$690K Buy
2,131
+14
+0.7% +$4.06K 0.01% 836
2019
Q3 		$579K Buy
2,117
+33
+2% +$12.1K 0.01% 860
2019
Q2 		$1.11M Buy
2,084
+38
+2% +$19.1K 0.02% 687
2019
Q1 		$1.03M Buy
2,046
+106
+5% +$62.8K 0.02% 698
2018
Q4 		$957K Buy
1,940
+7
+0.4% +$4.23K 0.02% 667
2018
Q3 		$1.77M Buy
1,933
+6
+0.3% +$5.12K 0.03% 508
2018
Q2 		$1.41M Buy
+1,927
New +$2.22M 0.03% 579

Other funds holding NKTR

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Utah Retirement Systems's NKTR Position: Q1 2021 in Review

Utah Retirement Systems sold out of Nektar Therapeutics (NKTR) in Q1 2021, closing a stake of 2,311 shares — an estimated $589K sold.

Utah Retirement Systems first reported a position in NKTR in Q2 2018 and held it in 11 quarters. The position peaked at $1.77M in Q3 2018. 235 funds tracked by Wall St. Rank hold NKTR as of Q1 2021.

  • Utah Retirement Systems reported no remaining Nektar Therapeutics position as of Q1 2021 after selling out during the quarter.
  • Utah Retirement Systems sold 2,311 Nektar Therapeutics shares in Q1 2021, an estimated $589K.
  • Utah Retirement Systems first reported a position in Nektar Therapeutics in Q2 2018 and held it in 11 quarters.
  • Utah Retirement Systems's Nektar Therapeutics position peaked at $1.77M in Q3 2018.
  • 235 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q1 2021.

Based on Utah Retirement Systems's 13F filing for Q1 2021, filed 17 May 2021.